Jacobs Levy Equity Management »

Zenas Biopharma shares owned by Jacobs Levy Equity Management

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Jacobs Levy Equity Management from 13F filings

Historical chart of Jacobs Levy Equity Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Jacobs Levy Equity Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Jacobs Levy Equity Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $538k 28k 19.55

More positions owned by Jacobs Levy Equity Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Booking Holdings (BKNG)
Qualcomm (QCOM)
Servicenow (NOW)
Target Corporation (TGT)
Amazon (AMZN)
Interactive Brokers Group In Com Cl A (IBKR)
General Motors Company (GM)
Fortinet (FTNT)
Lockheed Martin Corporation (LMT)
Bank of New York Mellon Corporation (BK)
Edwards Lifesciences (EW)

View all positions for Jacobs Levy Equity Management

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
Capital Research and Management Company - Division 3
Fairmount Funds Management
BlackRock
NVP Associates
Vanguard Group
Vanguard Capital Management
Polar Capital Holdings
Alliancebernstein
Wellington Management Company
EcoR1 Capital

View all funds holding Zenas Biopharma